Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2000
03/30/2000WO1999057565A3 Methods for diagnosing and evaluating cancer
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999051744A3 A interleukin-1 receptor antagonist and uses thereof
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000WO1999038980A3 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/30/2000DE19859115A1 Verwendung von Tumorzellen zeitversetzt in Kombination mit intakten Antikörpern zur Immunisierung Using time delay of tumor cells in combination with intact antibodies for immunization
03/30/2000CA2344669A1 Diagnostic assays for detection of entamoeba histolytica
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae
03/30/2000CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343320A1 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
03/30/2000CA2343052A1 Methods of treating ige-associated disorders and compositions for use therein
03/30/2000CA2343004A1 Alzheimer's disease secretase
03/30/2000CA2342957A1 Regulatory protein from human keratinocytes
03/30/2000CA2342783A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2283540A1 Anti-fas antibodies
03/29/2000EP0988382A1 Human protein phosphatase ii-c-like protein
03/29/2000EP0988381A1 T-cell receptor beta-like protein
03/29/2000EP0988380A1 Translational regulator initiation factor 4e-binding protein
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988378A1 A method for in vitro molecular evolution of protein function
03/29/2000EP0988376A2 Noey2 gene compositions and methods of use
03/29/2000EP0988321A2 B7-binding molecules for treating immune diseases
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988317A2 Aib1, a steroid receptor co-activator
03/29/2000EP0988063A2 Process for reducing the concentration of viral and molecular pathogens in a biological material
03/29/2000EP0988054A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
03/29/2000EP0988049A2 Pharmaceutical composition for treating hepatitis b virus (hbv) infection
03/29/2000EP0988047A1 Soluble ctla4 mutant molecules and uses thereof
03/29/2000EP0697891B1 Polyoxime compounds and their preparation
03/29/2000CN1248921A Methods of therapeutic administration of anti-CD40L compounds
03/29/2000CN1248625A Novel human gene coding sequence, its coded polypeptide and preparation process thereof
03/29/2000CN1248624A Novel human capside protein subunit coding sequence, its coded polypeptide and preparation process
03/29/2000CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process
03/28/2000US6043348 Antibody recognizing a small subset of human hematopoietic cells
03/28/2000US6043347 Compositions and methods for treating viral infections
03/28/2000US6043346 Antibody that binds to a tub polypeptide
03/28/2000US6043345 Isolated functional immunoglobulin e having an epsilon constant region wherein ch4'is spliced directly to ch5; for use in immune hypersensitivity diagnosis and treatment
03/28/2000US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide
03/28/2000US6043216 An autocrine crystal adhesion inhibitor is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (com) crystals to the cell surface.
03/28/2000US6043215 Preparation of factor IX
03/28/2000US6043088 Nucleotide sequence; dna and rna probes for diagnosis; anticarcinogenic/antitumor agents; vectors for gene therapy
03/28/2000US6043087 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
03/28/2000US6043086 Antibody produced by the hybridoma deposited with atcc with accession number hb-12555 against inflammatory brain chemokine; antiinflammatory agents
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043071 GlmU
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents
03/28/2000US6043042 Antibody which binds cleavage fragment of nerve cell peptide produced by action of a toxin; for immunoassays
03/28/2000US6043040 Csak-3 nucleic acid molecules and uses therefor
03/28/2000US6043030 Cell-cycle regulatory proteins, and uses related thereto
03/28/2000US6042836 HIV envelope polypeptides
03/28/2000US6042833 Cellular internalization of pIgR stalk and associated ligands
03/28/2000US6042830 Viral agent associated with mystery swine disease
03/28/2000US6042828 Humanized antibodies to ganglioside GM2
03/28/2000US6042827 Anti-idiotypic antibody induction of anti-tumor response
03/28/2000US6042826 Administering intrathecally or intralesionally a therapeutically effective amount of a fas-crosslinking component selected from an agonsit antihuman fas monoclonal antibody, anti-human fas bid fragments, or soluble fas-ligand
03/28/2000US6042824 Combining the substrate and a crosslinked enzyme crystal formulation containing a crosslinked enzyme and a surfactant which acts upon the substrate in presence of organic solvent or aqueous-organic solvent to form a product
03/28/2000CA2008735C Human epidermal growth factor (egf) receptor sequences and egf competitive monoclonal antibodies
03/28/2000CA2002144C Method of preventing or reducing eosinophilia
03/23/2000WO2000016103A1 Method for detecting or quantifying basophils and eosinophils
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015838A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015796A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015772A2 Recombinant protein production in urine
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015760A1 Streptococcal c beta protein compositions
03/23/2000WO2000015759A1 Interleukin 17-like receptor protein
03/23/2000WO2000015666A2 Compositions and methods for the treatment of tumors
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015260A1 Anti-ige gene therapy
03/23/2000WO2000015259A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000WO2000015250A2 Fibroblast inhibitor
03/23/2000WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
03/23/2000WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
03/23/2000WO2000008160A3 A plant disease resistance signalling gene: materials and methods relating thereto
03/23/2000WO2000000611A3 14273 receptor, a g-protein coupled receptor
03/23/2000WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
03/23/2000WO1999067269A9 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999061909A3 Methods and compositions for the detection of human herpesvirus
03/23/2000WO1999060115A3 Proteins and genes useful as tumor markers
1 ... 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 ... 1494